Drug quality monitoring, Zexi will bear the weight for you

Recently, the National Medical Products Administration issued a notice on the quality of drug sampling, and has taken risk control measures such as suspending the sale and use, recalling several batches of drugs that do not meet the regulations.

Drugs are special commodities closely related to human health and safety. In order to ensure the safety of people's medication, the government has been continuously increasing its supervision of the quality of pharmaceutical products. Since the beginning of this year, the National Medical Products Administration has actually issued multiple notices on drug quality inspections, and a large number of drugs have been discontinued or recalled. In order to strengthen drug quality supervision and ensure public medication safety, many places have also launched supervision and inspection of drug production, operation, and use units. Quality control is the top priority for the healthy development of the pharmaceutical industry.

Zexi Biological Fully Automatic Colony Counting and Antibacterial Zone (Antibiotic Efficacy) Measuring Instrument

The series of instruments developed by Zexi Biotechnology, including fully automatic colony counting and antibacterial zone (antibiotic potency) measuring instruments, have entered the market with the requirement of meeting the requirements of the State Administration for Market Regulation for food and drug testing computer information systems. In recent years, the system has been gradually improved through cooperation with pharmaceutical companies in various regions, and a multi-level and mutually restrictive safety management guarantee system has been constructed, ensuring the safety of the system, the completeness and authenticity of data, and meeting the needs of the State Administration for Market RegulationRequirements for GMP audit tracking. Example:

* In September 2020, Service Stone Pharmaceutical Group completed the "MeasurementtetracyclineThe chemical potency”Project report;

* In December 2020, Service Yiling Pharmaceutical completed the experimental report on "Penicillin Potency Determination";

* In June 2021, Shanghai Yan'an Pharmaceutical completed the experimental testing of "residues of aminoglycoside antibiotics";

* In October 2021, Shandong Qifa Pharmaceutical completed the identification processβ - lactam antibiotics”Project testing;

* In October 2021, Qilu Pharmaceutical completed the "Aseptic Testing of Antibiotics" project;

* In June 2022, Yanyuan, Huili, Yuexi, and Zhaojue Food and Drug Administration completed the "Food and Drug Safety Testing in the Daliangshan Mountain Area" project;

And serve multiple regional disease control centers to complete testing projects.

This series of instruments is directly connected to microcomputersUSB interface connection, no need for traditional receiving cards. Improved the speed of image processing by microcomputers, made the instrument work more stably, greatly reduced the failure rate, and had a high degree of automation and easy operation. The fully automatic enclosed dark box used in the instrument hardware,canEliminate external interference, with up and down light sources, shadowless lighting, professional camera high-definition lens, resulting in clearer imaging and more accurate results. And the control panel is fully touch sensitive, simplifying complexity and making it easy to get started.

Zexi Biotechnology will continue to innovate and actively cooperate with drug quality supervision work to provide strong guarantees for drug safety testing data.